NFE2L2 and neoplasm: Data generated in preclinical models demonstrated that treatment with a specific type, dose, and schedule of a selenium-containing molecule has dual effects on the expression levels of Nrf2 in tumor vs. normal tissues, downregulating its expression in tumors and upregulating it in normal tissues (Figure 4).